Home Journals Articles Updates About
CN
image
收藏切换
Research Progress on Mechanism of Astragaloside Ⅳ in Treatment of Diabetic Retinopathy
收藏切换
Xiaotong LIU1, Junqiang NIU1, Xiaoquan YAO1, Miao SUN1, Wenli ZHANG1, Tingting CHEN2, Yurui ZHAN1
Chinese Archives of Traditional Chinese Medicine | 2026, 44(9) : 236 - 241
Less
收藏切换
Chinese Archives of Traditional Chinese Medicine | 2026, 44(9): 236-241
• Platform of Provincial Project •
Research Progress on Mechanism of Astragaloside Ⅳ in Treatment of Diabetic Retinopathy
Full
Xiaotong LIU1, Junqiang NIU1, Xiaoquan YAO1, Miao SUN1, Wenli ZHANG1, Tingting CHEN2, Yurui ZHAN1
Affiliations
  • 1.Department of Traditional Chinese Medicine, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China
  • 2.The First School of Clinical Medicine of Lanzhou University, Lanzhou 730000, Gansu, China
Published: 2026-09-10 doi: 10.13193/j.issn.1673-7717.2026.09.044
Outline
收藏切换

Diabetic retinopathy (DR) is one of the most frequent and serious retinal microvascular complications of diabetic mellitus (DM), which belongs to the category of intraocular disturbance diseases of traditional Chinese medicine. Astragaloside Ⅳ (AS-Ⅳ), the main active component of Huangqi (Astragali Radix), integrates multiple pharmacological targets that align with the complex pathogenesis of DR. For the past few years, numerous studies have focused on the impact of AS-Ⅳ on DR, confirming its effects through various mechanisms such as hypoglycemic effect, anti-oxidative stress damage, inhibition of vascular endothelial growth factor (VEGF), anti-apoptosis of retinal cells, suppression of inflammatory responses, and inhibition of ferroptosis, thereby obstructing the occurrence and progression of DR through multiple pathways and targets. This paper mainly reviewed the research progress of AS-Ⅳ on the treatment of DR in order to provide reference for its further development and utilization and clinical application.

traditional Chinese medicine  /  traditional Chinese medicine monomer  /  astragaloside Ⅳ  /  diabetic retinopathy  /  mechanism of action  /  review
刘小通, 牛军强, 姚晓泉, 孙邈, 张文丽, 陈亭亭, 詹玉蕊. 黄芪甲苷对糖尿病视网膜病变作用机制研究进展. 中华中医药学刊, 2026 , 44 (9) : 236 -241 . DOI: 10.13193/j.issn.1673-7717.2026.09.044
Xiaotong LIU, Junqiang NIU, Xiaoquan YAO, Miao SUN, Wenli ZHANG, Tingting CHEN, Yurui ZHAN. Research Progress on Mechanism of Astragaloside Ⅳ in Treatment of Diabetic Retinopathy[J]. Chinese Archives of Traditional Chinese Medicine, 2026 , 44 (9) : 236 -241 . DOI: 10.13193/j.issn.1673-7717.2026.09.044
Appendix
Less
Year 2026 volume 44 Issue 9
84
15
Cite this Article
BibTeX
Article Info
doi: 10.13193/j.issn.1673-7717.2026.09.044
  • Online Date：2026-10-20
  • Published：2026-09-10
Article Data
Affiliations
History
Funding
Affiliations
    1.Department of Traditional Chinese Medicine, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China
    2.The First School of Clinical Medicine of Lanzhou University, Lanzhou 730000, Gansu, China
References
Share
https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2026.09.044
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House